# Study of GRAd-COV2 for the Prevention of COVID-19 in Adults

> **NCT04791423** · PHASE2,PHASE3 · COMPLETED · sponsor: **ReiThera Srl** · enrollment: 10300 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** GRAd-COV2
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04791423
- **Lead sponsor:** ReiThera Srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2021-06-04
- **Final completion:** 2022-05-13
- **Target enrollment:** 10300 (ACTUAL)
- **Last updated:** 2023-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04791423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04791423, "Study of GRAd-COV2 for the Prevention of COVID-19 in Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04791423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*